Skip to main content
OpenTrials

Clinical trial condition

Triple Negative Breast Neoplasms

Explore clinical trials studying Triple Negative Breast Neoplasms. Study availability and eligibility vary by location and protocol.

818 public trials 296 recruiting studies
Refine in advanced search Browse all conditions

Triple Negative Breast Neoplasms trial results

Recruiting

A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)

NCT06926868

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +4 more
Locations
  • Local Institution - 0303 Hot Springs, Arkansas, United States
  • Helios Clinical Research Cerritos, California, United States
  • Local Institution - 0307 Cerritos, California, United States
  • Local Institution - 0308 Cerritos, California, United States
View all 295 locations
View Trial Details
Recruiting

A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types

NCT04300556

Conditions
Adenocarcinoma, Adnexal Diseases, Breast Diseases, +33 more
Locations
  • ACRC/Arizona Clinical Research Center, Inc Tucson, Arizona, United States
  • Universty of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Stanford Women's Cancer Center Palo Alto, California, United States
  • University of Miami Coral Gables, Florida, United States
View all 58 locations
View Trial Details
Recruiting

Phase 1 Study of CLR 125 in Triple Negative Breast Cancer

NCT07311993

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
Locations
  • Mayo Clinic Florida Jacksonville, Florida, United States
  • United Theranostics Glen Burnie, Maryland, United States
  • Mayo Clinic Rochester Rochester, Minnesota, United States
  • United Theranostics Princeton, New Jersey, United States
View Trial Details
Recruiting

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

NCT04981119

Conditions
Adenocarcinoma, Adenoma, Adnexal Diseases, +65 more
Locations
  • Banner Health Gilbert, Arizona, United States
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • City of Hope Duarte, California, United States
  • University of California San Diego La Jolla, California, United States
View all 16 locations
View Trial Details
Recruiting

First in Human Study of TUB-030 in Patients With Advanced Solid Tumors

NCT06657222

Conditions
Advanced Solid Tumors, Breast Diseases, Breast Neoplasms, +16 more
Locations
  • Yale Cancer Center New Haven, Connecticut, United States
  • University of Miami Miami, Florida, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Mayo Clinic Rochester, Minnesota, United States
View all 16 locations
View Trial Details

Related conditions